ClinicalTrials.govpublic full text
Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec
colorectal cancer, colorectal, second line therapy, k-ras or b-raf mutations, response rate, progression free survival, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 896443
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.